Dergiler / Diagnostic and Interventional Radiology / 2021 / Cilt: 27 - Sayı: 2

Application of percutaneous transluminal sharp recanalization in transjugular intrahepatic portosystemic shunt for patients with chronic portal vein occlusion

Sayfa
247–262
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The cumulative rates of primary andsecondary shunt patency were 66.67% and 100%, respectively, at 2 years.CONCLUSIONAs a supplementary method, PTSR is a feasible and safe method for portal vein recanalizationwhen performing TIPS for patients with CPVO and portal hypertension

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:PURPOSEWe aimed to evaluate the feasibility and safety of a modified technique for portal vein recanalization, percutaneous transluminal sharp recanalization (PTSR), when performing transjugularintrahepatic portosystemic shunt (TIPS) for the treatment of chronic portal vein occlusion (CPVO)and portal hypertension.METHODSNine consecutive patients with CPVO and portal hypertension had undergone TIPS and PTSRprocedure after failing in conventional percutaneous catheterization from March 2017 to July2019.
📊
Temel Bulgular & Veri:Technical success rates, effectiveness, and complications were evaluated.
💡
Sonuç & Katkı:The cumulative rates of primary andsecondary shunt patency were 66.67% and 100%, respectively, at 2 years.CONCLUSIONAs a supplementary method, PTSR is a feasible and safe method for portal vein recanalizationwhen performing TIPS for patients with CPVO and portal hypertension
🔬Tür:Araştırma Makalesi
📍Kapsam:2017 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

PURPOSEWe aimed to evaluate the feasibility and safety of a modified technique for portal vein recanalization, percutaneous transluminal sharp recanalization (PTSR), when performing transjugularintrahepatic portosystemic shunt (TIPS) for the treatment of chronic portal vein occlusion (CPVO)and portal hypertension.METHODSNine consecutive patients with CPVO and portal hypertension had undergone TIPS and PTSRprocedure after failing in conventional percutaneous catheterization from March 2017 to July2019. Technical success rates, effectiveness, and complications were evaluated. Follow-up of patients’ clinical outcomes and shunt patency were performed periodically. Primary and secondaryshunt patency were analyzed by Kaplan-Meier method.RESULTSThe occluded portal veins were successfully recanalized after failing in conventional percutaneous catheterization, and TIPS procedures were completed in all 9 patients. Two patients sufferedfrom procedure-related complications. A portosystemic pressure gradient <12 mmHg, or a percent reduction of 25% to 50% of baseline, was achieved in all 9 patients after TIPS. During themedian follow-up period of 28 months (range, 9–36 months), 1 patient experienced recurrentascites and the other 8 patients remained asymptomatic. The cumulative rates of primary andsecondary shunt patency were 66.67% and 100%, respectively, at 2 years.CONCLUSIONAs a supplementary method, PTSR is a feasible and safe method for portal vein recanalizationwhen performing TIPS for patients with CPVO and portal hypertension

🔖

Bu Makaleye Atıf Yap

Lİ, M., LUO, J., CHEN, J., WU, C., PAN, T., HUANG, M., JİANG, Z. (2021). Application of percutaneous transluminal sharp recanalization in transjugular intrahepatic portosystemic shunt for patients with chronic portal vein occlusion. Diagnostic and Interventional Radiology, Cilt: 27 - Sayı: 2, 247–262. https://ajindex.com/articles/349947

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol 2016
  2. 179–202. [Crossref] 2. Garcia-Pagán JC, Hernández-Guerra M, Bosch J. Extrahepatic portal vein thrombosis. Semin Liver Dis 2008
  3. 282–292. [Crossref] 3. Wu M, Schuster M, Tadros M. Update on management of portal vein thrombosis and the role of novel anticoagulants. J Clin Transl Hepatol 2019
  4. 154–164. [Crossref] 4. Senzolo M, Tibbals J, Cholongitas E, Triantos CK, Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 2006
  5. 767–775. [Crossref] 5. Van Ha TG, Hodge J, Funaki B, et al. Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis. Cardiovasc Intervent Radiol 2006
  6. 785–790. [Crossref] 6. Wils A, van der Linden E, van Hoek B, Pattynama PM. Transjugular intrahepatic portosystemic shunt in patients with chronic portal vein occlusion and cavernous transformation. J Clin Gastroenterol 2009
  7. 982–984. [Crossref] 7. Fanelli F, Angeloni S, Salvatori FM, et al. Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma. Dig Liver Dis 2011
  8. 78–84. [Crossref] 8. Han G, Qi X, He C, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol 2011
  9. 78–88. [Crossref] 9. Qi X, Han G, Yin Z, et al. Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients. Dig Dis Sci 2012
  10. 1072–1082. [Crossref] 10. Habib A, Desai K, Hickey R, et al. Portal vein recanalization–transjugular intrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis. J Vasc Interv Radiol 2015
  11. 499–506. [Crossref] 11. Chen Y, Ye P, Li Y, Ma S, Zhao J, Zeng Q. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications. Eur Radiol 2015
  12. 3431–3437. [Crossref] 12. Luo J, Li M, Zhang Y, et al. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with